Src is a major signaling component for CTGF induction by TGF-beta1 in osteoblasts

Area of Science:

• Molecular Biology
• Cell Signaling
• Biochemistry

Background:

• Connective tissue growth factor (CTGF/CCN2) is a key mediator of transforming growth factor beta1 (TGF-β1)-induced matrix production in osteoblasts.
• The signaling pathways (Src, Erk, Smad) involved in CTGF induction by TGF-β1 are known, but their interactions remain unclear.

Purpose of the Study:

• To elucidate the interaction among Src, Erk, and Smad signaling pathways in TGF-β1-induced CTGF production in osteoblasts.
• To determine the role of Src as an upstream regulator of Erk and Smad activation in this process.

Main Methods:

• Utilized ROS17/2.8 osteoblast cells.
• Employed Src family kinase inhibitor (PP2) and Erk inhibitor (PD98059) to assess pathway involvement.
• Analyzed protein activation, nuclear translocation, and transcriptional complex formation using Western blotting and reporter assays.

Main Results:

• TGF-β1 activates Src kinase, which is essential for subsequent Erk and Smad activation and nuclear translocation.
• Inhibition of Src prevents TGF-β1-induced CTGF production and Erk/Smad activation.
• Erk inhibition blocks CTGF protein expression and Smad binding element (SBE) transactivation but does not affect Src or Smad activation/translocation.

Conclusions:

• Src is a critical upstream signaling transducer for both Erk and Smad pathways in TGF-β1-mediated CTGF induction in osteoblasts.
• Erk and Smad pathways function independently but are both required for the formation of a transcriptionally active complex on the CTGF promoter.